-
-
Tues - Fri: Call For Hours
-
1321 Old Oak Place, Montgomery, AL. 36117
-
(334)386-3551
Tues - Fri: Call For Hours
1321 Old Oak Place, Montgomery, AL. 36117
(334)386-3551
Put simply, medications like GLP-1, marketed as Wegovy or Ozempic, helps to enhance insulin sensitivity. This leads to the burning of calories and fat, along with an improvement in energy levels. GLP-1 is a peptide that functions by mimicking the actions of a hormone known as glucagon-like peptide 1 (GLP-1), which targets a part of the brain responsible for regulating hunger and food consumption. By managing blood sugar levels, curbing spikes, and decreasing cravings and appetite, GLP-1 helps maintain more consistent energy levels. It is administered via a subcutaneous injection, typically given once weekly, with the option to adjust the dosage if necessary after one month.

Surveys have shown that one out of every three participants achieves a 20% reduction in body weight through the program. Additionally, one out of every two participants experiences a 15% decrease in body weight. On average, GLP-1 by itself can contribute to a weight loss of 2-4 pounds per week.
Achieve actual weight loss outcomes ranging from 2-4 pounds per week.
Benefit from a potent appetite suppressant.
Enhance insulin sensitivity, facilitate fat burning, and increase energy levels.
Experience safety and effectiveness with a once-weekly injection.
There is a high success rate when combined with DWTP medical weight loss programs
FDA approval has been granted for weight loss.
** GLP-1 injections may cause nausea. Please let us know if you experience any nausea and we will prescribe and dispense you nausea medication. **
Month 1: Weeks 1-4 injections will be 0.25 mL once weekly
Month 2: Weeks 5-8 injections will be 0.50 mL once weekly
Month 3: Weeks 9-12 injections will be 1.0 mL once weekly
If normal BMI is not acheived after week 12 the dosing will titrate up to 2.4mg/mL.
Month 4: Weeks 13-16 injections will be 0.70 mL once weekly
Month 5: Weeks 17 onward injections will be 0.50 mL once weekly
If normal BMI is not acheived after 17 or more weeks a final maintenance dose will be given of 2.4mg/mL monthly.
